Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Victor Velculescu
Johns Hopkins University, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Personal Genome Diagnostics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The SFIs that result from the equity, fiduciary role, payment for services, and entitlement to intellectual property royalties could be affected by the research. Upon review by the institution, it was determined that Dr. Velculescu’s SFIs could directly and significantly affect the design, conduct or reporting of his research under this award.
Large-Scale Genetic Analyses of Human Cancer
PROJECT NARRATIVE The research project in this application is focused on using genome-wide analyses to provide insights into mechanisms of response and resistance to immune targeted therapies, including immune checkpoint blockade. The proposed studies are likely to lead to a greater understanding of tumor evolution and evasion during these therapies, improved approaches for patient selection and tumor monitoring, and new avenues for diagnostic and therapeutic intervention.
Filed on December 06, 2018.
Tell us what you know about Victor Velculescu's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Victor Velculescu filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Victor Velculescu | Johns Hopkins University | Conflict of Interest | Personal Genome Diagnostics | $100,000 - $149,999 |
| Victor Velculescu | Johns Hopkins University | Conflict of Interest | Roche | Value cannot be readily determined |
| Victor Velculescu | Johns Hopkins University | Conflict of Interest | Sysmex Corporation | Value cannot be readily determined |
| Victor Velculescu | Johns Hopkins University | Conflict of Interest | Qiagen GmbH | Value cannot be readily determined |
| Victor Velculescu | Johns Hopkins University | Conflict of Interest | Personal Genome Diagnostics | Value cannot be readily determined |
| Victor Velculescu | Johns Hopkins University | Conflict of Interest | Novartis AG | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.